Search results for "Steatosi"

showing 10 items of 261 documents

Fatty liver indexandhepatic steatosis index for prediction ofnon-alcoholic fatty liver disease in type 1 diabetes

2017

Background and Aim Little is known about the diagnostic value of hepatic steatosis index (HSI) and fatty liver index (FLI), as well as their link to metabolic syndrome in type 1 diabetes mellitus. We have screened the effectiveness of FLI and HSI in an observational pilot study of 40 patients with type 1 diabetes. Methods FLI and HSI were calculated for 201 patients with type 1 diabetes. Forty patients with FLI/HSI values corresponding to different risk of liver steatosis were invited for liver magnetic resonance study. In-phase/opposed-phase technique of magnetic resonance was used. Accuracy of indices was assessed from the area under the receiver operating characteristic curve. Results Tw…

medicine.medical_specialtyType 1 diabetesWaistHepatologyReceiver operating characteristicbusiness.industryfungiFatty liverGastroenterologymedicine.diseaseLikelihood ratios in diagnostic testingNephropathy03 medical and health sciences0302 clinical medicineEndocrinology030220 oncology & carcinogenesisInternal medicinemedicine030211 gastroenterology & hepatologyMetabolic syndromeSteatosisbusinessJournal of Gastroenterology and Hepatology
researchProduct

CT and MR imaging of chemotherapy-induced hepatopathy.

2019

Chemotherapy-induced hepatopathy includes a wide variety of parenchymal and vascular hepatic changes on imaging, including diffuse or focal hepatopathies (i.e. hepatitis, steatosis, fibrosis, pseudocirrhosis, or sinusoidal obstruction). These changes can profoundly alter the hepatic parenchyma on imaging and result in both false negative and false-positive diagnoses of hepatic metastases and lead to errors in patient management strategies. It is therefore important for radiologists to have a comprehensive knowledge of the imaging patterns that may develop following chemotherapy. The purpose of this review is to explore the broad spectrum of hepatic parenchymal and vascular chemotherapy-indu…

medicine.medical_specialtyUrologymedicine.medical_treatment030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineFibrosisInternal medicineParenchymamedicineHumansRadiology Nuclear Medicine and imagingHepatitisChemotherapyRadiological and Ultrasound Technologymedicine.diagnostic_testChemotherapy Hepatopathy Computed tomography Magnetic resonance imaging Sinusoidal obstruction syndromebusiness.industryGastroenterologyMagnetic resonance imagingHepatologymedicine.diseaseMr imagingMagnetic Resonance Imaging030220 oncology & carcinogenesissense organsRadiologySteatosisChemical and Drug Induced Liver InjurybusinessTomography X-Ray ComputedAbdominal radiology (New York)
researchProduct

Focal hepatic intrinsically hyperattenuating lesions at unenhanced CT: Not always calcifications.

2021

Due to the growing use of CT, there has been an increase in the frequency of detecting focal liver lesions. Intrinsically hyperattenuating hepatic lesions or pseudolesions are not uncommon at unenhanced CT. Hyperattenuating hepatic lesions can be divided into non-calcified and calcified. Causes of intrinsic hyperattenuation include hemorrhage, thrombosis, and calcifications. Focal liver lesions can show hyperattenuation on unenhanced CT in case of severe liver steatosis. Recognition of etiologies associated with hyperattenuation on unenhanced CT can help the radiologist in characterizing focal liver lesions and pseudolesions. In this paper, we describe the spectrum of intrinsically hyperatt…

medicine.medical_specialtybusiness.industryHyperattenuating hepatic pseudolesionLiver NeoplasmsCalcinosismedicine.diseaseThrombosisUnenhanced CTHepatic calcified lesionsDiagnosis DifferentialFatty LiverLiver steatosisIntrinsically hyperattenuating hepatic lesionLiver calcificationsmedicineHumansRadiology Nuclear Medicine and imagingRadiologyLiver calcificationsbusinessTomography X-Ray ComputedClinical imaging
researchProduct

Biochemical biomarkers of NAFLD/NASH

2020

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the Western world and the global epidemics of obesity and type 2 diabetes have led to a dramatic increase of its prevalence and incidence. Among NAFLD patients, those with nonalcoholic steatohepatitis (NASH) have a double risk of fibrosis progression, that is the main driver toward the evolution in cirrhosis and its complications, including hepatocellular carcinoma and hepatic decompensation. Furthermore, patients with NAFLD are also at risk for cardiovascular diseases and extrahepatic malignancies, that represent the first and the second cause of death, respectively. The availability of non-invasi…

medicine.medical_specialtyeducation.field_of_studyCirrhosisSteatosismedicine.diagnostic_testbusiness.industryPopulationNASHLiver fibrosiType 2 diabetesmedicine.diseaseChronic liver diseaseGastroenterologydigestive system diseasesLiver biopsyInternal medicineHepatocellular carcinomaNAFLDNonalcoholic fatty liver diseasemedicinebusinesseducationNon-invasive assessmentCause of death
researchProduct

PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes

2011

Context: Recently, it has been shown that an allele in the adiponutrin (PNPLA3) gene was strongly associated with increased liver fat content (LFC) and liver fibrosis independent of visceral adiposity and insulin resistance. Objective: In this study, we set out to determine whether the PNPLA3 rs738409 polymorphism was associated with liver fibrosis in unselected patients with type 2 diabetes. Design, setting and participants: Two hundred and thirty-four patients with type 2 diabetes were included in this study. Main outcome measures: LFC was evaluated using 1H-MR spectroscopy; fibrosis was measured using the non-invasive FibroTest®. Results: Advanced liver fibrosis (stage F2 or above) was o…

medicine.medical_specialtyeducation.field_of_studyHepatologybusiness.industryFibroTestType 2 diabetesmedicine.diseaseGastroenterologyEndocrinologyInsulin resistanceFibrosisPolymorphism (computer science)Internal medicinemedicineAdiponutrinSteatosisbusinesseducationBody mass indexLiver International
researchProduct

Rare <i>Atg7</i> Genetic Variants Predispose to Severe Fatty Liver Disease

2021

Background&Aims: Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease and has a strong heritable component. The aim of this study was to identify new genes involved in NAFLD pathogenesis. Methods: We examined rare variants captured by whole-exome sequencing in individuals with severe fibrosis or hepatocellular carcinoma due to NAFLD (severe NAFLD, n=301) after variant prioritization.  We replicated the results in the UK Biobank and the Liver biopsy cohort (n=2268). Results: We observed an enrichment of the p.P426L variant (rs143545741 C>T; OR=7.2, 2.3-17.3; p C; MAF=0.060 vs. 0.035; OR=1.7, 1.2-2.5; p=0.003). In the UK Biobank cohort, the p.V471A variant wa…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryFatty livermedicine.diseaseChronic liver diseaseGastroenterologyPathogenesisLiver diseaseBallooning degenerationLiver biopsyInternal medicineHepatocellular carcinomamedicineSteatosisbusinessSSRN Electronic Journal
researchProduct

Fat and liver transplantation: clinical implications

2018

Nonalcoholic steatohepatitis (NASH), with or without hepatocellular carcinoma, is a growing indication for liver transplantation (LT) worldwide, particularly in the Western world. Patients with NASH typically combine features of metabolic syndrome with cardiovascular comorbidities, which challenge pre-LT evaluation, surgical approaches, post-LT management, and outcomes. Post-LT survival in NASH patients is excellent, similar to that achieved with other indications, particularly in the absence of cardiovascular comorbidities. Although disease recurrence on the liver allograft is common, progression to advanced disease is uncommon, at least in the short term. Whether this holds true with long…

medicine.medical_specialtymedicine.medical_treatmentDisease030230 surgeryLiver transplantation03 medical and health sciences0302 clinical medicineNon-alcoholic Fatty Liver DiseaseRecurrenceNonalcoholic fatty liver diseasemedicineHumansIntensive care medicineTransplantationbusiness.industrymedicine.diseaseTissue DonorsLiver TransplantationNatural historysurgical procedures operativeHepatocellular carcinomaDonation030211 gastroenterology & hepatologySteatosisMetabolic syndromebusinessTransplant International
researchProduct

One or two ligatures inducing periodontitis are sufficient to cause fatty liver

2017

Background Periodontitis is a chronic disease that due to an intense inflammatory response triggers systemic changes such as hepatic alterations. This study aimed to compare hepatic damage in rats that received experimental periodontitis at one or two periodontal sites with ligatures. Material and Methods Eighteen rats were separated into three groups: control, without ligature; periodontitis 1, with one ligature; and periodontitis 2, with two ligatures. The following parameters were assessed: gingival bleeding index, probing pocket depth, tooth mobility, alveolar bone loss, malondialdehyde (MDA) and myeloperoxidase (MPO) activity in periodontal tissue; histopathological evaluation of hepat…

medicine.medical_specialtymedicine.medical_treatmentGastroenterology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicineAnimalsRats WistarPeriodontitisLigatureLigationGeneral DentistryDental alveolusPeriodontitisOral Medicine and PathologybiologyCholesterolbusiness.industryResearchFatty liver030206 dentistrymedicine.diseaseMalondialdehyde:CIENCIAS MÉDICAS [UNESCO]RatsFatty LiverOtorhinolaryngologychemistryMyeloperoxidaseUNESCO::CIENCIAS MÉDICASbiology.proteinFemale030211 gastroenterology & hepatologySurgerySteatosisbusiness
researchProduct

Effects of dietary conjugated linoleic acids in the control of adiposity and obesity‐related disorders

2007

The body fat-lowering effect of conjugated linoleic acids (CLA) in experimental animals has attracted much interest because of the potential use of CLA as weight loss agents in humans. The objective of this review was to give an overview of the results from human intervention trials. The review also addresses experimental studies in animal models and in cultured cells. CLA appear to provoke fat mass loss and an increase of fat-free mass in rodents, but the results in humans are inconsistent and much less clear than in rodents. Thus, the results of studies in humans do not support a body fat-lowering effect of CLA. There are indications from animal studies that the trans-10, cis-12 CLA isome…

medicine.medical_specialtymedicine.medical_treatmentLinoleic acidConjugated linoleic acidBiologyIndustrial and Manufacturing Engineeringchemistry.chemical_compoundInsulin resistanceLiver steatosisInternal medicinemedicinechemistry.chemical_classificationintegumentary systemInsulinfood and beveragesGeneral Chemistrymedicine.diseaseObesityEndocrinologyBiochemistrychemistrylipids (amino acids peptides and proteins)Animal studiesFood ScienceBiotechnologyPolyunsaturated fatty acidEuropean Journal of Lipid Science and Technology
researchProduct

Post‐COVID ‐19 Liver Injury: Comprehensive Imaging With Multiparametric Ultrasound

2021

OBJECTIVES: This study aimed to define patterns of liver injury after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection using multiparametric ultrasound (mpUS) in a variable patient population with differing severities of COVID-19. METHODS: Ninety patients were enrolled into the study: 56 had SARS-CoV-2 3-9 months prior to enrolment; 34 served as a clinically healthy control group. All patients underwent an mpUS evaluation of the liver (elastography, dispersion and attenuation imaging). Seventy-six patients had abdominal magnetic resonance (MR) and noncontrast enhanced thoracic computed tomography (CT) scans performed at the same day. All patients were screened for bioc…

medicine.medical_specialtymultiparametric ultrasoundCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)GastroenterologyCOVID‐19FibrosisInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingPandemicsUltrasonographyOriginal ResearchLiver injuryRadiological and Ultrasound Technologymedicine.diagnostic_testSARS-CoV-2business.industryUltrasoundCOVID-19Magnetic resonance imagingmedicine.diseaseLiverElastographySteatosisbusinessliver injuryJournal of Ultrasound in Medicine
researchProduct